American Express (AXP)

One commands premium lending with concentrated risk; the other sprawls across insurance, energy, and rails with a fortress balance sheet.

Israel Englander's Millennium Management has significant options exposure to the iShares Russell 2000 ETF, but investors need to examine why that's the case.

American Express is attracting and retaining card members across generations, showing why the business is built to last.

Shares in the premium payments firm have dropped 12% in 2026.

Insurance companies are among the largest institutional investors, thanks to this unique feature of their business.

American Express sold off after reporting earnings, but the company is at the top of its game.

Amex had strong Q2 revenue and earnings growth, but rising expenses are concerning.

The iconic credit card company continues to feast on the premium borrower.

According to a new report from Intel Market Research, the global Co-Branded Neobanking (Retail + Bank) Market was valued at USD 16.23 billion in 2025 and i

Financial institutions play a critical role, offering everything from consumer banking to wealth management and specialized financial solutions. Still, inves...

Amex recently reported its 2026 second-quarter earnings.

The major indexes bounced back Friday on falling oil prices. Here's what's driving the divergence between old-economy gains and tech-sector jitters.

American Express beat earnings estimates and raised guidance. Wall Street sold off anyway. Here's why.

Why did American Express (AXP) stock drop after strong Q2 results? Get the details on revenue, spending growth, and costs.

American Express (NYSE:AXP) reported second-quarter results that extended its recent growth momentum, with revenue rising 10% and earnings per share reaching $4.53. The company raised its full-year revenue-growth outlook to 10% while maintaining its EPS forecast of $17.30 to $17.90, saying it plans

US stocks mixed, Dow Jones up 0.2%. Real estate shares up 1.3%. American Express falls 6%. Ohmyhome, LiveWire, Vivakor surge. Robin Energy, RADIOPHARM, Codexis down.